- Home
- WSC vs SRPT Comparison
WSC vs SRPT Comparison
Compare WSC & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WSC | SRPT |
|---|---|---|
| Founded | 1944 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Misc Corporate Leasing Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.5B |
| IPO Year | 2015 | 2000 |
Fundamental Metrics
Financial Performance| Metric | WSC | SRPT |
|---|---|---|
| Price | $18.92 | $21.09 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 29 |
| Target Price | $24.14 | ★ $25.85 |
| AVG Volume (30 Days) | 1.8M | ★ 3.2M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.47% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,281,446,000.00 | $2,198,237,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.54 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 15.58 |
| 52 Week Low | $14.91 | $10.42 |
| 52 Week High | $31.88 | $64.80 |
Technical Indicators
Market Signals| Indicator | WSC | SRPT |
|---|---|---|
| Relative Strength Index (RSI) | 52.27 | 52.70 |
| Support Level | $18.49 | $20.61 |
| Resistance Level | $19.63 | $23.25 |
| Average True Range (ATR) | 0.79 | 1.21 |
| MACD | 0.26 | -0.10 |
| Stochastic Oscillator | 77.97 | 33.09 |
Price Performance
Historical ComparisonAbout WSC WillScot Mobile Mini Holdings Corp.
WillScot Holdings Corp designs, delivers, and services on-site, on-demand space solutions for clients. The company offers turnkey solutions in construction, education, manufacturing, retail, healthcare, and entertainment sectors. The products of the company include modular office complexes, mobile offices, classrooms, blast-resistant modules, clearspan structures, sanitation solutions, portable storage containers, and climate-controlled containers and trailers.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.